Loading
Latest filing published 17 Sept 2026 for 엔젠바이오.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by 에스에이치헬스케어투자1호조합 on record concern 엔젠바이오. In total, 13 filings cover trades dated from 16 May 2025 to 17 September 2026.
The open-market side counts 6 purchases alongside 3 sales. The totals exclude 9 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 3 purchases and 2 sales.
Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 17 September 2026: a transaction, in 엔젠바이오. The clock since the last published purchase (10 July 2026) now reads 107 days. The median gap between a trade and its publication by DART (FSS) is 5 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations